![](https://www.diabetesnews.com/wp-content/uploads/2012/04/mmw_money_052208_article-150x150.jpg)
People who pay for Lantus might be puzzled if they hear that the company that makes the popular insulin is in trouble. In 2013, sales of Lantus earned Sanofi some $8 billion, and the drug company felt comfortable enough to raise the price of its basal insulin twice in a year.